Drawing for KREAMEDICA

USPTO serial 50092146

KREAMEDICA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with KREAMEDICA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas P. Gulick

Thomas P. Gulick McNees Wallace & Nurick LLC100 Pine StreetHarrisburg, PA 17101United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting services in the fields of biotechnology and pharmaceuticals; business project management services for biotechnology and pharmaceutical companies; business management of outsourcing; business administration of relationships with contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs); business development services, namely, providing qualified business sales leads to contract research organizations and contract development and manufacturing organizationsACTIVE—
036Capital investment services; venture capital financing services; providing financing to biotechnology companiesACTIVE—
042Scientific research consulting in the fields of biotechnology and pharmaceutical development; consulting services relating to preclinical and clinical drug development strategies; technical coordination of chemistry, manufacturing, and controls (CMC) workflows for pharmaceutical products; research and development project management in the field of new pharmaceutical products; regulatory consulting services relating to the scientific development of pharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 4, 2026NWAPNEW APPLICATION ENTERED—
Sep 4, 2026MAFRAPPLICATION FILING RECEIPT MAILED—

Frequently asked questions

Related guidance